Trial intelligence / Profile preview

Gastrodin benzyl alcohol ester tablets in mild to moderate vascular dementia

CTR20160895Phase 2Completed

Sponsor
Beijing Collab Pharmaceutical Development
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gastrodin benzyl alcohol ester in vascular dementia, sponsored by Beijing Collab Pharmaceutical Development. Started Dec 2016; status: completed.

02

Drugs

gastrodin benzyl alcohol ester
03

Conditions

vascular dementia

Beyond the preview

Go deeper on CTR20160895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call